Xconomy | National - Business + Technology in the Exponential Economy

Archives

by in
Entry Blogger Date Location
After Re-Engineering Itself, Verdezyne Sets Course to Develop Biofuels and “Green” Industrial Chemicals Bruce V. Bigelow 11/20/09 San Diego
ISB Nabs $8M for Cancer Genome Luke Timmerman 11/10/09 Seattle
Life Technologies Acquiring BioTrove Bruce V. Bigelow 11/10/09 San Diego
Helicos Takes Itself Off Block Luke Timmerman 11/09/09 Boston
Ion Torrent, Stealthy Company Tied to Harvard’s George Church, Nabs $23M Venture Deal Luke Timmerman 11/06/09 Boston
Dendreon Files FDA Application, DxBox Reaches Turning Point, ISB to Do 100 Genomes, & More Seattle-Area Life Sciences News Luke Timmerman 11/05/09 Seattle
ISB Cuts Deal to Sequence 100 Genomes Luke Timmerman 11/02/09 Seattle
Sage Bionetworks, Biology’s Open Source Spark, Snags “Major” Donation from Quintiles Luke Timmerman 10/06/09 Seattle
UW Gets $25M For Genome Center Luke Timmerman 10/02/09 Seattle
Helicos Biosciences, Running Low on Cash, Snaps Up $10M Lifeline Luke Timmerman 09/16/09 Boston
What Will Seattle Biotech Be Like in 20 Years? Xconomy Event Looks Far Into Region’s Future Luke Timmerman 09/10/09 Seattle
Ambit Biosciences, In Third Incarnation, Gears Up for Pivotal Study of Leukemia Drug Luke Timmerman 09/10/09 San Diego
OVP Company Does 14 Genomes Luke Timmerman 09/09/09 Seattle
Trubion Scores $20M, Archus Shuts Down, AVI Biopharma’s Hope for Muscular Dystrophy, & More Seattle-Area Life Sciences News Luke Timmerman 09/03/09 Seattle
The Rosetta Diaspora: Genetics Talent Stays Close to Home After Merck Shuts Down in Seattle Luke Timmerman 09/02/09 Seattle
Can The Genome Be Cracked for $5,000? OVP, Enterprise Partners Say Yes in $45M Round Luke Timmerman 08/24/09 National
Amgen’s Personalized Strategy for Cancer Pays Off in Big Colon Cancer Trial Luke Timmerman 08/10/09 National
Stephen Friend, Leaving High-Powered Merck Gig, Lights Fire for Open Source Biology Movement Luke Timmerman 08/06/09 Seattle
Inside the Microsoft-Yahoo Deal, Covance Buys Merck’s Rosetta Lab, Delve Teams Up with Akamai, & More Seattle-Area Deals News Gregory T. Huang 08/04/09 Seattle
Vulcan’s Biotech Windfall, Tekmira Tackles RNAi Delivery, The $1,000 Genome Debate, & More Seattle-Area Life Sciences News Luke Timmerman 05/28/09 Seattle
Genologics Aims to Turn Patient Records, Genome Data into Something Biologists Can Use Luke Timmerman 05/27/09 Seattle
X Prize Founder Peter Diamandis Targets Breakthroughs With More Incentive Prizes Bruce V. Bigelow 05/22/09 San Diego
The $1,000 Genome is Coming: How Will It Change the World? Luke Timmerman 05/21/09 Seattle
Knome Offers Thriftier Gene Sequencing Roxanne Palmer 05/18/09 Boston
Google, Microsoft May Help Usher in Personalized Medicine Wave, Says George Church Luke Timmerman 05/12/09 Boston
Novocell Hires John West as CEO Luke Timmerman 05/11/09 San Diego
RainDance Reports $6M Financing Ryan McBride 05/07/09 Boston
Illumina Sues Affymetrix for Patent Infringement of Genetic Analysis Technology Juha-Pekka Tikka 05/05/09 San Diego
Urbanspoon Exits, Likewise Lands $10M, Zymo Licenses Drugs to Startup, & More Seattle-Area Deals News Gregory T. Huang 05/05/09 Seattle
Illumina Anticipates Purchasing Slowdown Juha-Pekka Tikka 04/22/09 San Diego
Page 1 of 2 next page »
    

Business, life sciences, and technology news — covering Boston, Seattle, San Diego, and beyond.

© 2007-2009, Xconomy, Inc. XCONOMY is a registered service mark of Xconomy, Inc. All rights reserved.
Site designed by Matthew Bouchard, produced by Andrew Koyfman, and powered by WordPress.